Anticarcinogenicity of monocyclic phenolic compounds

European Journal of Cancer Prevention

Volumn 11, Issue SUPPL. 2, 2002, Pages

  Williams, G M ^a   Iatropoulos, M J ^a   Jeffrey, A M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acetaminophen; Anticarcinogenicity; Antimutagenicity; Butylated hydroxyamisole; Butylated hydroxytoluene; Phenolics

Indexed keywords

2',3 DIMETHYL 4 BIPHENYLAMINE; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; AFLATOXIN B; ANTHRACYCLINE; ANTIMUTAGENIC AGENT; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CAFFEIC ACID; CATECHOL; ESTRAGOLE; EUGENOL; FERULIC ACID; GALLIC ACID; HYDROQUINONE; HYDROXYCHAVICOL; HYDROXYTYROSOL; MALONALDEHYDE; MESYLIC ACID METHYL ESTER; METHYLNITRONITROSOGUANIDINE; N (2 FLUORENYL)ACETAMIDE; PARA COUMARIC ACID; PARACETAMOL; PHENOL DERIVATIVE; PROTOCATECHUIC ACID; SINAPIC ACID; TYROSOL; UNCLASSIFIED DRUG; VANILLIC ACID; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOTRANSFORMATION; CANCER PREVENTION; CELL PROTECTION; COLON CANCER; CONCENTRATION RESPONSE; CONFERENCE PAPER; DETOXIFICATION; DNA BINDING; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GENOTOXICITY; LIVER CANCER; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMOPROPHYLAXIS; HUMAN; METHODOLOGY; NEOPLASM; RAT; REVIEW; SENSITIVITY AND SPECIFICITY;

ACETAMINOPHEN; ANIMALS; ANTICARCINOGENIC AGENTS; BUTYLATED HYDROXYANISOLE; BUTYLATED HYDROXYTOLUENE; CHEMOPREVENTION; HUMANS; NEOPLASMS; RATS; SENSITIVITY AND SPECIFICITY;

EID: 0036701566     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Amonkar AJ, Padma PR, Bhide SV (1989). Protective effect of hydroxychavicol, a phenolic component of betel leaf, against the tobacco-specific carcinogens. Mutat Res 210: 249-53.
2. Awasthi YC, Partridge CA, Dao DD (1983). Effect of butylated hydroxytoluene on glutathione S-transferase and glutathione peroxidase activities in rat liver. Biochem Pharmacol 32: 1197-200.
3. Chung FL, Wang M, Carmella SG, Hecht SS (1986). Effects of butylated hydroxyanisole on the tumorgenicity and metabolism of N-nitrosodimethylamine and N-nitrosopyrrolidine in A/J mice. Cancer Res 46: 165-8.
4. Cohen LA, Polansky M, Furuya K, Reddy M, Berke B, Weisburger JH (1984). Inhibition of chemically induced mammary carcinogenesis in rats by short-term exposure to butylated hydroxytoluene (BHT): Interrelationships among BHT concentration, carcinogen dose, and diet. J Natl Cancer Inst 72: 165-172.
5. Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER (1998). Over-the-counter analgesics and risk of ovarian cancer. Lancet 351: 104-7.
6. 1 and N-methyl-N′-nitro-N-nitrosoguanidine by certain phenolic compounds. Cancer Lett 45: 177-82.
7. Furukawa K, Maeura Y, Furukawa NT, Williams GM (1984). Induction by butylated hydroxytoluene of rat liver gamma-glutamyl transpeptidase activity in comparison to expression in carcinogen-induced altered lesions. Chem Biol Interact 48: 43-58.
8. Grantham PH, Weisburger JH, Weisburger EK (1973). Effect of the antioxidant butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide and N-hydroxy-N-2- fluorenylacetamide. Food Cosmet Toxicol 11: 209-17.
9. Hagiwara A, Kokubo Y, Takesada Y, et al. (1996). Inhibitory effects of phenolic compounds on development of naturally occurring preneoplastic hepatocytic foci in long-term feeding studies using male F344 rats. Teratog Carcinog Mutagen 16: 317-25.
10. Hudson AE, Dinh PA, Kokubun T, Simmonds MSJ, Gescher A (2000). Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 9: 1163-70.
11. Lindenschmidt RC, Tryka AF, Witschi H (1987). Modification of gastrointestinal tumor development in rats by dietary butylated hydroxytoluene. Fund Appl Toxicol 8: 474-81.
12. Maeura Y, Williams GM (1984). Enhancing effect of butylated hydroxytoluene on the development of liver altered foci and neoplasms induced by N-2-fluorenylacetamide in rats. Food Chem Toxicol 22: 191-8.
13. McKee RH, Tometsko AM (1979). Inhibition of promutagen activation by the antioxidants butylated hydroxanisole and butylated hydroxytoluene. J Natl Cancer Inst 63: 473-7.
14. Muscat JE, Stellman SD, Wynder EL (1995). Analgesic use and colorectal cancer. Prev Med 24: 110-12.
15. Nakagawa Y, Hiraga K, Suga T (1981). Effects of butylated hydroxytoluene (BHT) on the level of glutathione and the activity of glutathione-S-transferase in rat liver. J Pharmacobiodyn 4: 823-6.
16. O'Donoghue J, Barber ED, Hill T, Aebi J, Fiorica L (1999). Hydroquinone: Genotoxicity and prevention of genotoxicity following ingestion. Food Chem Toxicol 37: 931-6.
17. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H (2000). Phenolic compounds and squalene in olive oils: The concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene. Food Chem Toxicol 38: 647-59.
18. Reddy BS, Sharma C, Mathews L (1983). Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2′-dimethyl-4-aminobiphenyl. Nutr Cancer 5: 153-8.
19. 1 metabolism and induced mutagenesis. Mutat Res 177: 229-39.
20. Shamberger RJ, Corlett CL, Beaman KD, Kasten BL (1979). Antioxidants reduce the mutagenic effect of malonaldehyde and betapropriolactone. Part IX. Antioxidants and cancer. Mutat Res 66: 349-55.
21. Shirai T, Fukushima S, Kowabe M, et al. (1991). Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2′-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. Carcinogenesis 12: 1335-9.
22. Singletary KW, Nelshoppen JM, Scardefield S, Wallig M (1992). Inhibition by butylated hydroxytoluene and its oxidative metabolites of DMBA-induced mammary tumorigenesis and of mammary DMBA-DNA adduct formation in vivo in the female rat. Food Chem Toxicol 30: 455-65.
23. Slaga TJ (1995). Inhibition of the induction of cancer by antioxidants. Adv Exp Med Biol 369: 167-74.
24. Sydor W, Jr, Lewis KF, Yang CS (1984). Effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene by mouse lung microsomes. Cancer Res 44: 134-8.
25. Tokumo K, Iatropoulos MJ, Williams GM (1991). Butylated hydroxytoluene lacks the activity of phenobarbital in enhancing diethylnitrosamine-induced mouse liver carcinogenesis. Cancer Lett 59: 193-9.
26. Ulland BM, Weisburger JH, Yamamoto RS, Weisburger EK (1973). Antioxidants and carcinogenesis: Butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet Toxicol 11: 199-207.
27. Wattenberg LW (1972). Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J Natl Cancer Inst 48: 1425-30.
28. Wattenberg LW (1985). Chemoprevention of cancer. Cancer Res 45: 1-8.
29. Weisburger EK, Evarts RP (1977). Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane. Food Cosmet Toxicol 15: 139-41.
30. Weisburger JH, Williams GM (1995). Causes of cancer. In American Cancer Society Textbook of Clinical Oncology (eds Murphy GP, Lawrence W Jr, Lenhard RE Jr); American Cancer Society, Atlanta, GA. pp. 10-39.
31. Weisburger, JH, Yamamato RS, Williams GM, Grantham PH, Matusushima T, Weisburger EK (1972). On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res 32: 491-500.
32. Whysner J, Williams GM (1996). Butylated hydroxyanisole mechanistic data and risk assessment: Conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71: 137-52.
33. Whysner J, Wang CX, Zang E, Iatropoulos MJ, Williams GM (1994). Dose response of promotion by butylated hydroxyanisole in chemically initiated tumours of the rat forestomach. Food Chem Toxicol 32: 215-22.
34. Willett WC (1994). Micronutrients and cancer risk. Am J Clin Nutr 59: 1162S-5S.
35. Williams GM (1993a). Food: Its role in the etiology of cancer. In Food and Cancer Prevention: Chemical and Biological Aspects (eds Waldron KW, Johnsen IT, Genwick GR); The Royal Society of Chemistry, Cambridge, UK, pp. 3-11.
36. Williams GM (1993b). Inhibition of chemical-induced experimental cancer by synthetic phenolic antioxidants. In Antioxidants: Chemical, Physiological, Nutritional and Toxicological Aspects (eds Williams GM, Sies H, Baker GT III, Erdman JW Jr, Henry CJ); Princeton Scientific Press, Princeton, NJ, pp. 303-8.
37. Williams GM (1994). Interventive prophylaxis of liver cancer. Eur J Cancer Prev 3: 89-99.
38. Williams GM (1999). Chemically induced rodent preneoplastic lesions as indicators of carcinogenic activity. In The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation (eds McGregor DB, Rice JM, Venitt S); IARC Scientific Publications No. 146. Lyon, France, pp. 185-202.
39. 1 in rats by low levels of the phenolic antioxidant butylated hydroxyanisole and butylated hydroxy toluene. Cancer Lett 104: 1-5.
40. Williams GM, Iatropoulos MJ (1997a). Anticarcinogenic effects of synthetic phenolic antioxidants. In Oxidants, Antioxidants, and Free Radicals (eds Baskin SI, Salem H); Taylor Francis, Washington DC, pp. 341-50.
41. Williams GM, Iatropoulos MJ (1997b). Inhibition by acetaminophen of intestinal cancer in rats induced by an aromatic amine similar to food mutagens. Eur J Cancer Prev 6: 357-62.
42. Williams GM, Wynder EL (1996). Diet and cancer: A synopsis of causes and prevention strategies. In Nutrition and Cancer Prevention (eds Watson RR, Mufti SI); CRC Press, Boca Raton, FL, pp. 1-12.
43. 1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis 7: 1043-50.
44. Williams GM, Wang CX, Iatropoulos MJ (1990). Butylated hydroxyanisole and butylated hydroxytoluene II. Chronic feeding studies. Food Chem Toxicol 28: 799-806.
45. Williams GM, Tanaka T, Maruyama H, Maeura Y, Weisburger JH, Zang E (1991). Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetylaminofluorene. Cancer Res 51: 6224-30.
46. Williams GM, Iatropoulos MJ, Jeffrey AM, Shirai T (2002). Protective effect of acetaminophen against colon cancer initiation effects of 3,2′-dimethyl-4-aminobiphenyl in rats. Eur J Cancer Prev 11: 39-48.
47. Yamamoto RS, Williams GM, Richardson HL, Weisburger EK, Weisburger JH (1973). Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide. Cancer Res 33: 454-7.
48. Yang CS, Sydor W, Jr, Martin MB, Lewis KF (1981). Effects of butylated hydroxyanisole on the aryl hydrocarbon hydroxylase of rats and mice. Chem Biol Interact 37: 337-50.
49. Yang EK, Kashfi K, Chowdhury JR, Chowdhury NR, Dannenberg AJ (1995). Phenolic antioxidants induce UDP-glucuronosyltransferase in rat liver. Ann NY Acad Sci 768: 231-6.
50. Zhu BT, Lech J, Rosen RT, Conney AH (1997). Effect of dietary 2(3)-tert-butyl-4-hydroxyanisole on the metabolism and action of estradiol and estrone in female CD-1 mice. Cancer Res 57: 2419-27.